{"transactions":[{"id":2153781,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77621,"kind":"person","name":"Sidhu Roger","position":1,"cik":"0001884115","reported_name":"Sidhu Roger","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2022-09-21T23:00:47.000Z","date":"2022-09-20","kind":"exercise","acquired":false,"shares":20163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit converts into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September, 2021, the reporting person was granted 80,650 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September, 2021, the reporting person was granted 80,650 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date."}],"balance_after":60487,"derivative":{"underlying":"Common Stock","underlying_shares":20163},"source":{"system":"sec-edgar","filing":"0001140361-22-034312","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122034312/form4.xml","form_type":"4"}},{"id":2153780,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77621,"kind":"person","name":"Sidhu Roger","position":1,"cik":"0001884115","reported_name":"Sidhu Roger","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-09-21T23:00:47.000Z","date":"2022-09-20","kind":"exercise","acquired":true,"shares":20163,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit converts into one share of common stock."}],"balance_after":20163,"source":{"system":"sec-edgar","filing":"0001140361-22-034312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122034312/form4.xml","form_type":"4"}},{"id":2329635,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77621,"kind":"person","name":"Sidhu Roger","position":1,"cik":"0001884115","reported_name":"Sidhu Roger","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2022-03-18T01:00:20.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":142100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable in 36 substantially equal monthly installments from the grant date."}],"balance_after":142100,"derivative":{"exercise_price":1.93,"expiration_date":"2032-03-11","underlying":"Common Stock","underlying_shares":142100},"source":{"system":"sec-edgar","filing":"0001140361-22-009980","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122009980/form4.xml","form_type":"4/A","original_submission_date":"2022-03-15"}},{"id":2334477,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77621,"kind":"person","name":"Sidhu Roger","position":1,"cik":"0001884115","reported_name":"Sidhu Roger","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2022-03-16T01:34:16.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":142100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable over three years, with 25% of the options vesting on the one-year anniversary of the grant date and the remaining options vesting in 24 substantially equal monthly installments thereafter."}],"balance_after":142100,"derivative":{"exercise_price":1.93,"expiration_date":"2032-03-11","underlying":"Common Stock","underlying_shares":142100},"source":{"system":"sec-edgar","filing":"0001140361-22-009660","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122009660/form4.xml","form_type":"4"}},{"id":2562544,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77621,"kind":"person","name":"Sidhu Roger","position":1,"cik":"0001884115","reported_name":"Sidhu Roger","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Unit","published_at":"2021-09-22T20:57:24.000Z","date":"2021-09-20","kind":"grant","acquired":true,"shares":80650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU Grant vests and becomes exercisable in four equal installments on September 20 of each of 2022, 2023, 2024 and 2025, provided that it shall vest in full immediately prior to a change in control (as defined in Dr. Sidhu's Executive Employment Agreement, effective September 20, 2021), subject to continued service through each vesting date."}],"balance_after":80650,"derivative":{"expiration_date":"2031-09-20","underlying":"Common Stock","underlying_shares":80650},"source":{"system":"sec-edgar","filing":"0001140361-21-032105","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036121032105/form4.xml","form_type":"4"}},{"id":2562543,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":77621,"kind":"person","name":"Sidhu Roger","position":1,"cik":"0001884115","reported_name":"Sidhu Roger","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option","published_at":"2021-09-22T20:57:24.000Z","date":"2021-09-20","kind":"grant","acquired":true,"shares":161300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over four years, with twenty-five percent of the shares covered thereby vesting on September 20, 2022, and 1/36 of the remaining shares covered thereby vesting on the twentieth day of each calendar month from October 2022 through September 20, 2025, subject to continued service through each vesting date."}],"balance_after":161300,"derivative":{"exercise_price":9.96,"expiration_date":"2031-09-20","underlying":"Common Stock","underlying_shares":161300},"source":{"system":"sec-edgar","filing":"0001140361-21-032105","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036121032105/form4.xml","form_type":"4"}}]}